Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Nacresertib with Itraconazole in Healthy Adults
NCT07649954Phase 1Completed
- Sponsor
- AbbVie Inc.
- Start
- Jun 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of nacresertib, sponsored by AbbVie Inc. Primary endpoints: Maximum Observed Plasma Concentration, Time to Maximum Observed Plasma Concentration and 4 more. Started Jun 2026; status: completed.
02
Drugs
nacresertib
Beyond the preview
Go deeper on NCT07649954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07649954.